RxDoctor Payments Data

Patrick Edwards, MD

Family Medicine · Coquille, ORNPI 1851351191

Payments from drug & device makers

$351in general payments, 2019–2025

Across 18 payments — averaging $19.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$97
  • Novo Nordisk$51
  • Amgen$37
  • Madrigal Pharmaceuticals$26
  • Boehringer Ingelheim$25
  • Daiichi Sankyo Inc.$22
  • plus $93 from 6 others

What the payments were for

  • Food & beverage$351100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$351 in reported general payments places this provider in the 75th percentile of 1,221 family medicine providers in Oregon.

See all family medicine providers in Oregon

Medicare billing

Part B allowed, 2024
$18,511
Medicare patients
58
Services billed
241

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban89$95,223
TrulicityDulaglutide35$45,895
OzempicSemaglutide27$32,570
JardianceEmpagliflozin28$32,297
Trelegy ElliptaFluticasone/Umeclidin/Vilanter35$22,120
MounjaroTirzepatide19$19,238
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog24$11,020
Breo ElliptaFluticasone/Vilanterol15$8,769
Incruse ElliptaUmeclidinium Bromide22$7,915
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen286$5,879
BrilintaTicagrelor12$4,789
Albuterol Sulfate HfaAlbuterol Sulfate112$4,358
Potassium Chloride144$4,072
Levothyroxine Sodium334$3,782
Gabapentin161$3,652

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Prempro$20$97,789101 claims
Lilly USA, LLCTrulicity, Mounjaro$18$65,13454 claims
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta$13$38,80472 claims
Novo NordiskOzempic$51$32,57027 claims
Boehringer IngelheimJardiance$25$32,29728 claims
AstraZenecaBrilinta$12$4,78912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,221 family medicine providers in Oregon.

Other family medicine in Coquille

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →